Navigation Links
Stanford doctors advance in bid to turn mice stem cells into blood vessels

Researchers at the Stanford University School of Medicine have taken a first step toward growing blood vessels from stem cells that could eventually be transplanted into living organisms.

Starting with embryonic stem cells derived from mice, surgical resident Oscar Abilez, MD, and colleagues have successfully differentiated the stem cells into myocytes, one of the building blocks of blood vessels, after placing them in a life-like growth environment that the research team had created. The scientists hope to be able to eventually grow whole blood vessels that can be transplanted back into mice.

The work is being performed in the laboratory of Christopher Zarins, MD, professor of surgery.

"It's very odd," Abilez said. "We get these stem cells and grow them into contracting myocytes in cultures: You really see them contracting, you really know they're alive, and you start to believe this stem cell stuff has possibilities."

For the study, Abilez received first place in the seventh annual International Society of Endovascular Fellows' research award in laboratory sciences. The findings are published in this month's edition of the Journal of Endovascular Therapy.

The ultimate goal of the research is to bring together two of today's most promising areas of medical investigation: stem cell research and tissue engineering. Tissue engineering, the growth of organs and tissues outside the body for replacement, has achieved successful transplantations of a variety of human tissues including skin and corneas. Most recently, a team of researchers at Wake Forest University in Winston-Salem, N.C., performed the successful transplantation of laboratory-grown bladders into seven children.

Tissue-engineered blood vessels have also seen some success when transplanted into animal models, but still face a variety of limitations, Abilez said, key among them rejection by the immune system. By creating a tissue-engineered blood vessel grown fro m a patient's own stem cells, this rejection could potentially be eliminated, Abilez said.

"Our goal is to derive all the different cell types from the same, original cell," Abilez explained. "This would be new for an engineered tissue. We hope our work with mouse stem cells could eventually be translated to human autologous adult stem cells."

With an estimated 70 million Americans diagnosed with cardiovascular disease, the need for arterial vascular grafts continues to grow. In 2002, there were 1.5 million medical procedures done that required replacement blood vessels.

"This is an exciting, emerging research front," said John Cook, MD, PhD, professor of medicine (cardiovascular medicine). "It has great potential for therapeutic applications."

Abilez's success is due in part to a custom-made bioreactor that researchers built in their laboratory; it has the capability of delivering controlled chemical, electrical and mechanical stimulation to the stem cells. Bioreactors have been used for centuries as fermentation chambers for growing organisms such as bacteria and yeast, but only recently have they been used in stem cell research labs.

"Oscar is the first one to really create an environment which cells see in real life," Zarins said. "He's the first one to really create the multiplicity of biomechanical stresses and strains that the vascular system experiences in everyday life when you simply get up and walk around the block." The computer-controlled bioreactor was developed to help create a standardized process for differentiating stem cells in laboratories that could be used around the world.

"The idea behind it is that you can control various conditions to try to make these stem cells become the cells you want," Abilez said. "Our goal is to take the mouse stem cells and find the conditions that will make the stem cells into smooth muscle cells (myocytes), endothelial cells and fibroblasts, which make up the three l ayers of a blood vessel. The idea is if we can optimize our yield we can more easily obtain the large number of specific cells required to make a blood vessel."


'"/>

Source:Stanford University Medical Center


Related biology news :

1. Same mutation aided evolution in many fish species, Stanford study finds
2. First real-time view of developing neurons reveals surprises, say Stanford researchers
3. Stem cells from brain transformed to produce insulin at Stanford
4. Stanford gut check shows diversity of intestinal ecosystem
5. Young Blood Revives Aging Muscles, Stanford Researchers Find
6. Stem cell training program to make its Stanford debut
7. Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds
8. Sooner is better with cochlear implants, Stanford scientist shows
9. Learning to love bacteria: Stanford scientist highlights bugs benefits
10. For one Stanford doctor, the beat goes on during open-heart surgery
11. Stanford study of owls finds link in brain between sight and sound
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/17/2016)... March 17, 2016 ABI Research, the ... the global biometrics market will reach more than ... increase from 2015. Consumer electronics, particularly smartphones, continue ... sensors anticipated to reach two billion shipments by ... Dimitrios Pavlakis , Research Analyst at ABI Research. ...
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ) - ... Images ( http://www.apimages.com ) - Germany . ... new refugee identity cards. DERMALOG will be unveiling this device, and ... Hanover next week.   --> Germany ... the new refugee identity cards. DERMALOG will be unveiling this device, ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells ... Advisory Board. Ross is the founder of GSCG affiliate Kimera Labs in Miami. , ... he studied hematopoietic stem cell transplantation for hematologic disorders and the suppression of graft ...
(Date:4/26/2016)... ANGELES, Calif. (PRWEB) , ... April 27, 2016 ... ... Angeles office of Lewis Roca Rothgerber Christie LLP as an associate in the ... prosecuting U.S. and international electrical, mechanical and electromechanical patent applications. He has an ...
(Date:4/26/2016)... ... 26, 2016 , ... Mr. Palmer created the RPO business for Ceridian and ... multi-year managed services contract in the U.S. intelligence community with The SI (a Lockheed ... John Younger, founder of Accolo. “We are growing and his experience guiding our ...
(Date:4/26/2016)... BUDAPEST, Hungary , VIENNA ... 26, 2016 The prize ... and the resulting revolutionary innovations that will benefit ... (Logo: http://photos.prnewswire.com/prnh/20160210/331945LOGO ) , ... developing novel proprietary trend setting products in the ...
Breaking Biology Technology: